Metabolomics for early-stage lung adenocarcinoma: diagnostic biomarker screening
Blood metabolomics has potential diagnostic value for E-LUAD. More medical studies are needed to verify whether the metabolic markers identified in the current research can be applied in clinical practice.
Authors
- Rufang Li
- Yunhui Zhang (ORCID: https://orcid.org/0000-0002-6291-9448)
- Danxiong Sun (ORCID: https://orcid.org/0009-0002-5069-9713)
- Yanhong Du
Institutions
- Kunming University of Science and Technology (CN)
- First People's Hospital of Yunnan Province (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-11
- DOI
- https://doi.org/10.3389/fonc.2025.1535525
- Citations
- 1
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.81